— Know what they know.
Not Investment Advice
Also trades as: COX.PA (PAR) · $vol 0M · ALCOX.PA (PAR) · $vol 0M

NICXF Earnings

Nicox S.A.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -83.0% 5Y: -93.8%
$0.30
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 41 · $29.2M mcap · 93M float · 0.0001% daily turnover
Last Earnings 2025-04-30
EPS
€-0.28 (US$-0.31)
▼ Miss +0.0%
Revenue
€2M ($3M)
▲ Beat +0.0%
Next Earnings 2026-05-12
EPS Estimate
€-0.47 (US$-0.52)
Range: €0.00 - €0.00
Revenue Estimate
€999K ($1M)
1 analysts
1 USD = 0.89 EUR

Estimate vs Actual

Earnings Surprise History

2/15
EPS Beats
3/15
Revenue Beats
13%
EPS Beat Rate
20%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-10-02 annual 2026-12-31 €-0.05 €-0.05 — €2,956,238 €2,952,668
2026-10-02 annual 2027-12-31 €0.02 €0.02 — €9,854,129 €9,842,227
2026-10-01 annual 2026-12-31 €-0.05 €-0.05 — €2,963,093 €2,956,238
2026-10-01 annual 2027-12-31 €0.02 €0.02 — €9,876,979 €9,854,129
2026-09-30 annual 2026-12-31 €-0.05 €-0.05 — €2,968,437 €2,963,093
2026-09-30 annual 2027-12-31 €0.02 €0.02 — €9,894,790 €9,876,979
2026-09-29 annual 2026-12-31 €-0.05 €-0.05 — €2,965,205 €2,968,437
2026-09-29 annual 2027-12-31 €0.02 €0.02 — €9,884,016 €9,894,790
2026-09-28 annual 2026-12-31 €-0.05 €-0.05 — €2,966,977 €2,965,205
2026-09-28 annual 2027-12-31 €0.02 €0.02 — €9,889,924 €9,884,016
2026-09-25 annual 2026-12-31 €-0.05 €-0.05 — €2,983,736 €2,966,977
2026-09-25 annual 2027-12-31 €0.02 €0.02 — €9,945,789 €9,889,924
2026-09-24 annual 2026-12-31 €-0.05 €-0.05 — €2,988,506 €2,983,736
2026-09-24 annual 2027-12-31 €0.02 €0.02 — €9,961,688 €9,945,789
2026-09-23 annual 2027-12-31 €0.02 €0.02 — €9,978,109 €9,961,688
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms